comparemela.com

Latest Breaking News On - Prnewswire armata pharmaceuticals inc - Page 3 : comparemela.com

Armata Pharmaceuticals to Participate in the H C Wainwright 1st Annual Investor Conference on Bacteriophage

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesJoyce allairePierre kymeLifesci advisorsArmata pharmaceuticals incPrnewswire armata pharmaceuticals incAnnual investor conferenceArmata pharmaceuticalsSci advisors

Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesBrian varnumJoyce allairePierre kymeUs department of defenseLifesci advisorsDefense health agencyArmata pharmaceuticals incWarfighter medical research programTechnology enterprise consortiumPrnewswire armata pharmaceuticals incRecent developmentsChief executive officerMedical technology enterprise consortiumJoint warfighter medical researchArmata pharmaceuticals

Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesBrian varnumJoyce allairePierre kymeUs department of defenseLifesci advisorsDefense health agencyArmata pharmaceuticals incWarfighter medical research programTechnology enterprise consortiumPrnewswire armata pharmaceuticals incRecent developmentsChief executive officerMedical technology enterprise consortiumJoint warfighter medical researchArmata pharmaceuticals

Armata Pharmaceuticals Announces First Quarter 2022 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesBrian varnumJoyce allairePierre kymeUs department of defenseLifesci advisorsDefense health agencyArmata pharmaceuticals incWarfighter medical research programInnoviva incTechnology enterprise consortiumPrnewswire armata pharmaceuticals incRecent developmentsChief executive officerMedical technology enterprise consortiumJoint warfighter medical research

Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesBrian varnumJoyce allaireSteve martinUs department of defenseLifesci advisorsDefense health agencyCystic fibrosis foundation therapeutics development awardArmata pharmaceuticals incWarfighter medical research programCf foundationInnoviva incPaycheck protection programTechnology enterprise consortiumPrnewswire armata pharmaceuticals incRecent developments

vimarsana © 2020. All Rights Reserved.